Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis P Seeman, D Weinshenker, R Quirion, LK Srivastava, SK Bhardwaj, ... Proceedings of the National Academy of Sciences 102 (9), 3513-3518, 2005 | 438 | 2005 |
Locus coeruleus: a new look at the blue spot GR Poe, S Foote, O Eschenko, JP Johansen, S Bouret, G Aston-Jones, ... Nature Reviews Neuroscience 21 (11), 644-659, 2020 | 413 | 2020 |
There and back again: a tale of norepinephrine and drug addiction D Weinshenker, JP Schroeder Neuropsychopharmacology 32 (7), 1433-1451, 2007 | 412 | 2007 |
Psychosis pathways converge via D2High dopamine receptors P Seeman, J Schwarz, JF Chen, H Szechtman, M Perreault, GS McKnight, ... Synapse 60 (4), 319-346, 2006 | 395 | 2006 |
The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice DF Manvich, KA Webster, SL Foster, MS Farrell, JC Ritchie, JH Porter, ... Scientific reports 8 (1), 3840, 2018 | 358 | 2018 |
Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity TN Taylor, WM Caudle, KR Shepherd, AR Noorian, CR Jackson, ... Journal of Neuroscience 29 (25), 8103-8113, 2009 | 304 | 2009 |
Norepinephrine: the redheaded stepchild of Parkinson's disease KS Rommelfanger, D Weinshenker Biochemical pharmacology 74 (2), 177-190, 2007 | 290 | 2007 |
Genetic and pharmacological analysis of neurotransmitters controlling egg laying in C. elegans D Weinshenker, G Garriga, JH Thomas Journal of Neuroscience 15 (10), 6975-6985, 1995 | 267 | 1995 |
Long road to ruin: noradrenergic dysfunction in neurodegenerative disease D Weinshenker Trends in neurosciences 41 (4), 211-223, 2018 | 242 | 2018 |
7, 8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer’s disease Z Zhang, X Liu, JP Schroeder, CB Chan, M Song, SP Yu, D Weinshenker, ... Neuropsychopharmacology 39 (3), 638-650, 2014 | 237 | 2014 |
RGS14 is a natural suppressor of both synaptic plasticity in CA2 neurons and hippocampal-based learning and memory SE Lee, SB Simons, SA Heldt, M Zhao, JP Schroeder, CP Vellano, ... Proceedings of the National Academy of Sciences 107 (39), 16994-16998, 2010 | 212 | 2010 |
Functional consequences of locus coeruleus degeneration in Alzheimer's disease D Weinshenker Current Alzheimer Research 5 (3), 342-345, 2008 | 211 | 2008 |
The role of catecholamines in seizure susceptibility: new results using genetically engineered mice D Weinshenker, P Szot Pharmacology & therapeutics 94 (3), 213-233, 2002 | 205 | 2002 |
Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice KS Rommelfanger, GL Edwards, KG Freeman, LC Liles, GW Miller, ... Proceedings of the National Academy of Sciences 104 (34), 13804-13809, 2007 | 199 | 2007 |
QseC Mediates Salmonella enterica Serovar Typhimurium Virulence In Vitro and In Vivo CG Moreira, D Weinshenker, V Sperandio Infection and immunity 78 (3), 914-926, 2010 | 195 | 2010 |
Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer’s disease JM Rorabaugh, T Chalermpalanupap, CA Botz-Zapp, VM Fu, ... Brain 140 (11), 3023-3038, 2017 | 188 | 2017 |
Good night and good luck: norepinephrine in sleep pharmacology HA Mitchell, D Weinshenker Biochemical pharmacology 79 (6), 801-809, 2010 | 181 | 2010 |
Amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity SW Jang, X Liu, CB Chan, D Weinshenker, RA Hall, G Xiao, K Ye Chemistry & biology 16 (6), 644-656, 2009 | 163 | 2009 |
Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease T Chalermpalanupap, B Kinkead, WT Hu, MP Kummer, T Hammerschmidt, ... Alzheimer's research & therapy 5, 1-9, 2013 | 162 | 2013 |
Norepinephrine-deficient mice have increased susceptibility to seizure-inducing stimuli P Szot, D Weinshenker, SS White, CA Robbins, NC Rust, ... Journal of Neuroscience 19 (24), 10985-10992, 1999 | 159 | 1999 |